Navigation Links
Oregon Health Care Quality Corporation Receives Important Designation from U.S. Department of Health and Human Services
Date:3/19/2008

Secretary Leavitt to present the Chartered Value Exchange designation and

meet with community leaders during March 20 visit to Portland

PORTLAND, Ore., March 19 /PRNewswire/ -- In recognition of the organization's efforts to improve care and physician practices in Oregon, The Oregon Health Care Quality Corporation (Quality Corp) is receiving the Chartered Value Exchange designation from the U.S. Department of Health and Human Services.

HHS is recognizing 14 community-based organizations around the country as the first Chartered Value Exchanges, and Secretary Leavitt will personally recognize Quality Corp during his Portland visit. The organization is being recognized for taking clear actions to convene community purchasers, health plans, providers and consumers to advance value-driven health care.

Specifically, Quality Corp is focused on the following efforts:

-- Giving people information that helps them be better partners with their

doctors in managing their own health.

-- Learning how doctors and hospitals how they can make improvements in

caring for patients.

-- Helping purchasers get the information they need in order to buy high

value health care.

-- Encouraging systems to get patients' information to where it is needed

for good care.

"Quality health care happens when doctors, nurses and patients are all on the same team with the same expectations," said Nancy Clarke, Executive Director of the Oregon Health Care Quality Corporation. "Information about cost and quality, provided in the right way, can encourage a much stronger partnership between patients and their provider teams, leading to better health."

The Quality Corp, in addition to other groups receiving the designation, will receive access to Medicare provider performance information for their communities, which can be combined with similarly calculated private-sector results to produce and publish all-payer performance results. The value exchanges will also become part of a nationwide Learning Network through which they can share experiences, best practices, and identify areas where innovation is needed.

"Currently, we don't have a sense of how we are doing in terms of delivering high value health care in Oregon," said Ralph Prows, M.D., Senior Medical Director for Regence and Chairman of Oregon Health Care Quality Corporation. "A cooperative approach to measuring care value -- one that focuses on improvement -- is the only way this will work. All of us -- doctors, hospitals, health plans, purchasers, patients, government -- can and will do better with good information."

About Oregon Health Care Quality Corporation:

The Oregon Health Care Quality Corporation is a non-profit partnership that brings together physician groups, nurses, hospitals, health plans, purchasers, consumers and policy makers to improve the quality of health care through collaborative leadership. The group focuses on projects that measure and report care quality, align quality improvement assistance to providers, engage consumers in a quality health care system, and foster electronic exchange of health information.


'/>"/>
SOURCE Oregon Health Care Quality Corporation
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Phlo Affiliate Reports Expanded Coverage to Oregon Border
2. Assured Pharmacy Consolidates Portland, Oregon Pharmacy
3. Hearing Scheduled in the Delaware Court of Chancery for August 27, 2007 to Establish the Valid Approval and Consummation of the Merger Between PharmAthene, Inc. and Healthcare Acquisition Corp.
4. Research Triangle Area Health Care Collaborative Launches Bridges to Excellence(R) Initiative to Improve Quality and Lower Costs
5. Healthcare Technologies Calls for a Shareholders Meeting to Approve the Nexgen Biofuels Transaction
6. Healthcare Technologies Reports Loss for 2007 Second Quarter & Six Months Results
7. Ohio Ranks Best in the Midwest for Venture Capital Investment in Health Care Bioscience Industry
8. Proceedings to Affirm Merger Between PharmAthene and Healthcare Acquisition Corp Initiated in Delaware Chancery Court
9. InterCure and Omron Healthcare (UK) Ltd. Announce Marketing Collaboration for Hypertension Market in United Kingdom
10. Apria Healthcare Chooses Masimo SET Pulse Oximetry for Use in the Companys Home Health Care Business
11. NuVasive to Present at Thomas Weisel Partners Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/23/2017)... 2017  GlobeImmune, Inc. today announced it has entered ... 12,835,490 shares of its common stock to NantCell, Inc., ... with the sale of its common stock, NantCell has ... to GlobeImmune 200,000 shares, an estimated $2.0 million in ... are pleased to enter into this strategic agreement with ...
(Date:3/23/2017)... 2017 According to a report by Transparency ... fragmented due to the presence of a large pool of participants; ... Fisher , and Sigma-Aldrich, compete with each other in this market. ... more than 76% of this market in 2016.  ... As of now, a large number ...
(Date:3/22/2017)... ... March 22, 2017 , ... Researchers face a fundamental ... samples to full-size tissues, bones, even whole organs to implant in people to ... blood deep into the developing tissue. , Current bioengineering techniques, including 3-D ...
(Date:3/22/2017)... LEXINGTON, Mass. , March 22, 2017   ... collections, today announced that Doctors Pathology Service ... mid-Atlantic region of the United States ... the Delaware Health Information Network (DHIN) to ... researchers. The novel program, announced in ...
Breaking Biology Technology:
(Date:3/6/2017)... March 6, 2017 Mintigo , ... today announced Predictive Sales Coach TM , its ... sales intelligence into Salesforce. This unique AI application ... sales organizations with deep knowledge of their customers ... intelligent engagement. Predictive Sales Coach extends Mintigo,s existing ...
(Date:3/2/2017)... 2, 2017 Australian stem cell and regenerative ... has signed an agreement with the Monash Lung Biology ... Discovery Institute and Department of Pharmacology at Monash University, ... preclinical study to support the use of Cymerus™ mesenchymal ... Asthma is a chronic, long term lung ...
(Date:2/28/2017)... 27. Februar 2017  EyeLock LLC, ein marktführendes Unternehmen ... erstklassige biometrische Lösung zur Iris-Erkennung auf der ... LTE auf dem Mobile World Congress 2017 ... in Halle 3, Stand 3E10, vorstellen. ... Qualcomm Haven™ – eine Kombination aus Hardware, ...
Breaking Biology News(10 mins):